A federal commission is calling for $15 billion in new financing to re-enforce the United States’ biotech leadership amid ...

Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed as the “DeepSeek moment” for China’s drug industry, as biotech ...

discusses the role of AI in accelerating the biotech sector in regions like China. Denmark's defense committee head said he regrets choosing the F-35: 'We must avoid American weapons if at all ...

This was supposed to be the year of biotech’s comeback. At least that was the hope of many in the sector who started 2025 pointing to scientific advances and falling interest rates. Some foresaw ...